Antibiotic resistance - the problem intensifies

被引：123

作者：

Levy, SB ^{[1
]}

机构：

[1] Tufts Univ, Sch Med, Ctr Adaptat Genet & Drug Resistance, Dept Mol Biol & Microbiol, Boston, MA 02111 USA

[2] Tufts Univ, Sch Med, Ctr Adaptat Genet & Drug Resistance, Dept Med, Boston, MA 02111 USA

来源：

ADVANCED DRUG DELIVERY REVIEWS | 2005年 / 57卷 / 10期

关键词：

antibiotic resistance; MRSA; fluoroquinolones; vancomycin; carbapenemases;

D O I：

10.1016/j.addr.2005.04.001

中图分类号：

R9 [药学];

学科分类号：

1007 ;

摘要：

While previously recognized antibiotic-resistant bacteria continue to increase in frequency and numbers globally, new resistance problems have recently emerged which further complicate and impede treatment of critical infectious diseases. Vancomycin resistance among Staphylococcus aureits, extended spectrum beta-lactamases among gram-negative pathogens, and fluoroquinolone resistance among already multidrug-resistant Escherichia coli and Neisseria gonorrheae are adding to the toll of resistance on patients suffering with infectious diseases. (c) 2005 Elsevier B.V. All rights reserved.

引用

收藏

页码：1446 / 1450

页数：5

相关论文

共 41 条

[1] GENETICS AND MECHANISMS OF GLYCOPEPTIDE RESISTANCE IN ENTEROCOCCI [J].

ARTHUR, M ;

COURVALIN, P .

ANTIMICROBIAL AGENTS AND CHEMOTHERAPY, 1993, 37 (08) :1563-1571

[2]

Avorn J, 2001, ANTIBIOTIC RESISTANC

[3] Growing group of extended-spectrum β-lactamases:: The CTX-M enzymes [J].

Bonnet, R .

ANTIMICROBIAL AGENTS AND CHEMOTHERAPY, 2004, 48 (01) :1-14

[4] Antibacterial susceptibility of a vancomycin-resistant Staphylococcus aureus strain isolated at the Hershey Medical Center [J].

Bozdogan, B ;

Esel, D ;

Whitener, C ;

Browne, FA ;

Appelbaum, PC .

JOURNAL OF ANTIMICROBIAL CHEMOTHERAPY, 2003, 52 (05) :864-868

[5] Extended-spectrum β-lactamases in the 21st century:: Characterization, epidemiology, and detection of this important resistance threat [J].

Bradford, PA .

CLINICAL MICROBIOLOGY REVIEWS, 2001, 14 (04) :933-951

[6] Infection with vancomycin-resistant Staphylococcus aureus containing the vanA resistance gene [J].

Chang, S ;

Sievert, DM ;

Hageman, JC ;

Boulton, ML ;

Tenover, FC ;

Downes, FP ;

Shah, S ;

Rudrik, JT ;

Pupp, GR ;

Brown, WJ ;

Cardo, D ;

Fridkin, SK .

NEW ENGLAND JOURNAL OF MEDICINE, 2003, 348 (14) :1342-1347

[7]

DAN M, 2002, MMWR-MORBID MORTAL W, V51, P1041

[8] Antimicrobial resistance among clinical isolates of Streptococcus pneumoniae in the United States during 1999-2000, including a comparison of resistance rates since 1994-1995 [J].

Doern, GV ;

Heilmann, KP ;

Huynh, HK ;

Rhomberg, PR ;

Coffman, SL ;

Brueggemann, AB .

ANTIMICROBIAL AGENTS AND CHEMOTHERAPY, 2001, 45 (06) :1721-1729

[9] VanE, a new type of acquired glycopeptide resistance in Enterococcus faecalis BM4405 [J].

Fines, M ;

Perichon, B ;

Reynolds, P ;

Sahm, DF ;

Courvalin, P .

ANTIMICROBIAL AGENTS AND CHEMOTHERAPY, 1999, 43 (09) :2161-2164

[10] Low dosage and long treatment duration of β-lactam -: Risk factors for carriage of penicillin-resistant Streptococcus pneumoniae [J].

Guillemot, D ;

Carbon, C ;

Balkau, B ;

Geslin, P ;

Lecoeur, H ;

Vauzelle-Kervroëdan, F ;

Bouvenot, G ;

Eschwége, E .

JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION, 1998, 279 (05) :365-370

← 1 2 3 4 5 →